Octagon Capital Advisors’s Cymabay Therapeutics CBAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-2,673,750
Closed -$63.2M 65
2023
Q4
$63.2M Sell
2,673,750
-400,000
-13% -$7.12M 10.1% 2
2023
Q3
$45.8M Sell
3,073,750
-1,497,168
-33% -$19.8M 8.07% 3
2023
Q2
$50.1M Hold
4,570,918
6.98% 3
2023
Q1
$39.9M Buy
4,570,918
+2,711,718
+146% +$21.7M 5.75% 4
2022
Q4
$11.7M Buy
+1,859,200
New +$7.07M 1.82% 14

Other funds holding CBAY